FICE
发表于 2025-3-23 13:27:47
http://reply.papertrans.cn/79/7816/781518/781518_11.png
hedonic
发表于 2025-3-23 16:54:32
Lev Kantorovichmay reveal limitations to the conceptions that seem to follow from the results. Policy, however, operates under a different set of constraints. Its concepts must be initially acceptable— otherwise it has little chance of being implemented, regardless of the facts. The usual function of facts is to l
Gobble
发表于 2025-3-23 21:08:48
http://reply.papertrans.cn/79/7816/781518/781518_13.png
填料
发表于 2025-3-24 00:26:38
Lev Kantorovichistinguished from those influences first mentioned for two reasons: First, studies of drug use and dependence attempt to uncover empirical generalizations about drugs, and second, because these findings are empirical, there is a hope that they guide, at least to some extent, the actions of other for
广大
发表于 2025-3-24 05:23:11
http://reply.papertrans.cn/79/7816/781518/781518_15.png
诱惑
发表于 2025-3-24 09:21:17
Lev Kantorovichinical, and industrial organizations and serves as indispensable resource for ophthalmic researchers, drug formulation scientists, drug delivery and drug disposition scientists, as well as clinicians involved in designing and developing novel therapeutics for the back of the eye diseases. This book
HUSH
发表于 2025-3-24 12:40:17
Lev Kantorovichinical, and industrial organizations and serves as indispensable resource for ophthalmic researchers, drug formulation scientists, drug delivery and drug disposition scientists, as well as clinicians involved in designing and developing novel therapeutics for the back of the eye diseases. This book
BUCK
发表于 2025-3-24 15:36:23
http://reply.papertrans.cn/79/7816/781518/781518_18.png
Astigmatism
发表于 2025-3-24 22:07:57
0168-1222of solids has required the development of a large array of mathematical tech niques. This is closely analogous to the challenge faced long ago by theoretical 978-1-4020-2153-4978-1-4020-2154-1Series ISSN 0168-1222 Series E-ISSN 2365-6425
强化
发表于 2025-3-25 02:08:39
Lev Kantorovichesearchers, drug formulation scientists, drug delivery and drug disposition scientists, as well as clinicians involved in designing and developing novel therapeutics for the back of the eye diseases. This book 978-1-4614-2819-0978-1-4419-9920-7Series ISSN 2210-7371 Series E-ISSN 2210-738X